Nexalin Technology Reinstates Nasdaq Compliance with Minimum Bid Price Requirement’
HOUSTON, TX, November 1, 2024 - In a significant development for its financial standing and market perception, Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW), an innovative leader in neurostimulation technology, has successfully regained compliance with the Nasdaq’s minimum bid price requirement as outlined in Nasdaq Rule 5550(a)(2). This announcement follows the Nasdaq Stock Market’s formal notice dated October 31, 2024, which signaled a return to good standing after Nexalin navigated the hurdles associated with stock price thresholds.
The restoration of compliance is a milestone that underscores Nexalin’s commitment to maintaining high standards of corporate governance and financial stewardship. As a member of the Nasdaq stock exchange, Nexalin is required to keep its common stock trading at or above a minimum bid price of $1.00 per share. Failure to meet this requirement for an extended period could have resulted in the delisting of Nexalin’s common stock, inhibiting the company’s access to vital public equity markets and possibly affecting investor confidence.
By achieving this compliance, Nexalin preserves its listing on one of the world’s most prestigious global stock exchanges, thereby enhancing its visibility and appeal to investors. It also secures the company’s potential to leverage additional market opportunities to further its ambitious s within the neurostimulation space.
As Nexalin continues to advance its technological innovations aimed at treating mental health disorders and other neurological conditions, the maintenance of its Nasdaq listing ensures ongoing access to capital and strategic partnerships. This compliance milestone serves as a testament to Nexalin’s resilience and adaptive strategies in a challenging financial landscape.
Moving forward, Nexalin remains focused on growth and expansion, supported by its robust research and development pipeline and an unyielding commitment to improving patient outcomes through cutting-edge technology. The company will continue to uphold its financial and operational standards to meet and exceed Nasdaq’s regulatory requirements, ensuring sustained investor confidence and long-term institutional stability.
Comments